investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Late Stage Lead Optimisation, Preclinical Development and Clinical Trial of Lysyl Oxidase (LOX) Inhibitors

Caroline Springer

0 Collaborator(s)

Funding source

Wellcome Trust (WT)
Late Stage Lead Optimisation, Preclinical Development and Clinical Trial of Lysyl Oxidase (LOX) Inhibitors

Related projects

Deborah Morrison

Regulation of Ras-Dependent Signal Transduction Pathways

Melanoma of skin

Marc Nicklaus

Synthetically Accessible Virtual Inventory (SAVI)

All cancers but non-melanoma skin cancer

Stuart Rankin

Design and synthesis of medium-ring compounds to target nucleotide binding sites

Melanoma of skin All cancers but non-melanoma skin cancer

Nicolas Tapon

Tissue growth control and mechanics during development

All cancers but non-melanoma skin cancer Melanoma of skin

Till Bartke

Molecular Mechanisms of Chromatin Regulation by DNA and Histone Modifications and Epigenetic Reader Molecules

Melanoma of skin All cancers but non-melanoma skin cancer

Jeremy Carlton

Tumour Suppressor Functions of Membrane Trafficking Pathways

All cancers but non-melanoma skin cancer Melanoma of skin

Tamara Dubowitz

Does a New Supermarket Improve Dietary Behaviors of Low-income African Americans?

All cancers but non-melanoma skin cancer

Rahul Roychoudhuri

Regulation of immune function by the transcription factor BACH2.

Melanoma of skin All cancers but non-melanoma skin cancer

Marc Nicklaus

Large Databases of Small Molecules - Drug Development Tool and Public Resource

All cancers but non-melanoma skin cancer